Author of A World Appears; This is Your Mind on Plants; How to Change Your Mind; Cooked; In Defense of Food; The Omnivore’s Dilemma, and The Botany of Desire.
Today's Microdose: Federal drug enforcement revives proposal to place five hallucinogens in Schedule I category; Oregon reverses planned fee increase for psilocybin licensees themicrodose.substack.com/p/…
The Mushroom Cure, my solo show about my quest to cure my OCD with mushrooms, plays Boston on Saturday.
We’re filming the performance for a feature film of the live show, executive produced by @michaelpollan.
1/ This new preprint on 'pain representation' in LLMs, from @camhberg and colleagues, is getting a LOT of attention - mainly from folks who take it as evidence supporting calls for AI welfare. I have a lot of respect for the authors, so let's take a look 👀
This week's Microdose: Definium trial suggests LSD could help treat anxiety; “One patient meets God. The other gets itchy.”; and Compass funds psilocybin-assisted therapist training themicrodose.substack.com/p/…
Antonio Damasio, a giant in the field of consciousness research, has a fascinating new book, out today: Natural Intelligence & the Logic of Consciousness by Antonio Damasio: 9798217207497 | PenguinRandomHouse.com: Books penguinrandomhouse.com/books…
The week's news in psychedelics: Psilocybin may help prevent chemo-induced nerve pain; Definium scores second FDA Breakthrough Therapy designation themicrodose.substack.com/p/…
Don't miss this fascinating story by BCSP-Ferriss Fellow Andrew LAwler: Mind-altering drugs played key role in rise of Andean civilization | Science | AAAS science.org/content/article/…
Here it is - the official, revised, peer-reviewed version of my Platonic Space paper. mdpi.com/2409-9287/11/5/161 Of all the many unpopular positions I’ve taken over the decades - bitter controversies around the origin of left-right asymmetry in embryogenesis, bioelectricity and genetics, diverse intelligence, etc., this one has by far generated the most pushback: serious (grateful for those!) and energetic attempts to move me to other views, pleas to just drop it and not talk about it (for several different reasons), nasty emails and accusations, impacts on reviews of papers that have nothing to do with this, etc. Kind of amazing to me how incendiary this is. What can I say... Our job is to call it as we see it, and right now for me, this is it. Apologies to collaborators and colleagues for any shrapnel! Time will tell if this pans out or not; I've placed my bets. And btw, if you think this stuff is weird and uncomfortable, just wait… There’s much more on the way. The knob turns slowly but as long as the data keep coming, I'm going to say what I think it all means and follow it to the next steps it enables. Buckle up!